Florida Medical Marijuana Card Program - To Start Now! Fill Out The Form Below
Raphael Mecholaum an Israeli organic chemist who discovered THC, and the endocannabinoid system, and has studied the marijuana plant for decades... “We have just scratched the surface,” he says, “and I greatly regret that I don’t have another lifetime to devote to this field, for we may well discover that cannabinoids are involved in some way in all human diseases.”
Crohn's Disease University of Nottingham researchers found in 2010 that chemicals in marijuana, including THC and cannabidiol, interact with cells in the body that play an important role in gut function and immune responses. The study was published in the Journal of Pharmacology and Experimental Therapeutics. THC-like compounds made by the body increase the permeability of the intestines, allowing bacteria in. The plant-derived cannabinoids in marijuana block these body-cannabinoids, preventing this permeability and making the intestinal cells bond together tighter. The researchers believe that a genetic susceptibility coupled with other triggers, such as diet, stress or bacterial imbalance, leads to a defective immune response. Crohn's disease, one of several inflammatory bowel diseases, achieved "complete remission" in nearly half the subjects of one study that were exposed to smoking medical marijuana on a regular basis.THC-rich cannabis produced significant clinical, steroid-free benefits to patients with active Crohn's disease, compared with placebo, without side effects. Source: Naftali T, Lihi BL, Iris D. Cannabis Induces a Clinical Response in Patients With Crohn's Disease: Clinical Gastroenterology and Hepatology. 2013.
Chron's Disease, IBS, Irritable Bowel Syndrome, Colitis, Inflammatory Bowel Disease, IBD
Here's a list of studies showing the benefits of cannabis for Crohn's disease, IBS (Irritable Bowel Syndrome), and colitis:
Crohn's Disease
-
Naftali, T., et al. (2013) - "Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study"
- This study demonstrated that cannabis can induce clinical remission in patients with Crohn's disease.
- Link to study
-
Lahat, A., et al. (2012) - "Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study"
- This pilot study suggested that cannabis use improves quality of life and clinical disease activity in patients with IBD, including Crohn's disease.
- Link to study
Irritable Bowel Syndrome (IBS)
-
Sexton, M., et al. (2016) - "Medical Cannabis and the Treatment of Irritable Bowel Syndrome"
- This study reviewed the potential benefits of medical cannabis in treating IBS symptoms, including abdominal pain and diarrhea.
- Link to study
-
Hasenoehrl, C., et al. (2017) - "Cannabinoids and the Gastrointestinal Tract: Relevance to Motility, Nausea and Pain"
- This review highlighted the role of cannabinoids in gastrointestinal motility, nausea, and pain, all of which are relevant to IBS.
- Link to study
Colitis
-
Storr, M.A., et al. (2010) - "Cannabinoid Receptor 2 Modulates Colonic Motility in Experimental Colitis"
- This study explored how cannabinoid receptor 2 activation can modulate colonic motility in colitis, suggesting potential therapeutic benefits.
- Link to study
-
Khan, M.I., et al. (2020) - "The Effect of Cannabinoids on Inflammatory Bowel Disease: A Review of the Literature"
- This review summarized various studies indicating that cannabinoids may reduce inflammation and improve symptoms in colitis.
- Link to study
These studies indicate promising potential for cannabis in managing symptoms and improving the quality of life for patients with Crohn's disease, IBS, and colitis. However, further research is necessary to fully understand the therapeutic benefits and optimal usage of cannabis for these conditions.